Iron oxide nanoparticulate system as a cornerstone in the effective delivery of Tc-99 m radionuclide: a potential molecular imaging probe for tumor diagnosis
- 25 Downloads
The evolution of nanoparticles has gained prominence as platforms for developing diagnostic and/or therapeutic radiotracers. This study aims to develop a novel technique for fabricating a tumor diagnostic probe based on iron oxide nanoparticles excluding the utilization of chelating ligands.
Tc-99 m radionuclide was loaded into magnetic iron oxide nanoparticles platform (MIONPs) by sonication. 99mTc-encapsulated MIONPs were fully characterized concerning particles size, charge, radiochemical purity, encapsulation efficiency, in-vitro stability and cytotoxicity. These merits were biologically evaluated in normal and solid tumor bearing mice via different delivery approaches.
99mTc-encapsulated MIONPs probe was synthesized with average particle size 24.08 ± 7.9 nm, hydrodynamic size 52 nm, zeta potential -28 mV, radiolabeling yield 96 ± 0.83%, high in-vitro physiological stability, and appropriate cytotoxicity behavior. The in-vivo evaluation in solid tumor bearing mice revealed that the maximum tumor radioactivity accumulation (25.39 ± 0.57, 36.40 ± 0.59 and 72.61 ± 0.82%ID/g) was accomplished at 60, 60 and 30 min p.i. for intravenous, intravenous with physical magnet targeting and intratumoral delivery, respectively. The optimum T/NT ratios of 57.70, 65.00 and 87.48 were demonstrated at 60 min post I.V., I.V. with physical magnet targeting and I.T. delivery, respectively. These chemical and biological characteristics of our prepared nano-probe demonstrate highly advanced merits over the previously reported chelator mediated radiolabeled nano-formulations which reported maximum tumor uptakes in the scope of 3.65 ± 0.19 to 16.21 ± 2.56%ID/g.
Stabilized encapsulation of 99mTc radionuclide into MIONPs elucidates a novel strategy for developing an advanced nano-sized radiopharmaceutical for tumor diagnosis.
KeywordsMagnetic iron oxide nanoparticles Tc-99 m radionuclide Chelator free radiolabeling Encapsulation Tumor delivery Tumor diagnosis
Associate Prof. Tamer M. Sakr expresses his grateful appreciation and thanks for International Atomic Energy Authority (IAEA) for international collaboration and funding this work under CRP No. F22064.
- 2.Xing Y, Zhao J, Shi X, Conti PS, Chen K. Recent development of radiolabeled nanoparticles for PET imaging. Austin J Nanomed Nanotechnol. 2014;2(2):1016.Google Scholar
- 11.Maria AVW, Margarida MCO, Marcela Z, Ariane JSB, Mohammed Q, Ralph SO. Nanoradiopharmaceuticals for nanomedicine: building the future. Recent Pat Nanomed. 2014;4(2):90–4.Google Scholar
- 12.Ting G, Chang CH, Wang HE. Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy. Anticancer Res. 2009;29:4107–18.Google Scholar
- 23.Khayatian G, Hassanpoor S, Azar ARJ, Mohebbi S. Spectrophotometric determination of trace amounts of uranium(VI) using modified magnetic iron oxide nanoparticles in environmental and biological samples. J Braz Chem Soc. 2013;24:1808–17.Google Scholar
- 25.Tsiapa I, Efthimiadou EK, Fragogeorgi E, Loudos G, Varvarigou AD, Bouziotis P, et al. 99mTc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of αvβ3-mediated tumor expression and feasibility for hyperthermia treatment. J Colloid Interface Sci. 2014;433:163–75.CrossRefGoogle Scholar
- 36.Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancerchemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46(12):6387–92.Google Scholar
- 45.Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283–318.Google Scholar
- 46.Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, et al. Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000;18(3–4):301–13.CrossRefGoogle Scholar